Active Surveillance for Low-Risk Prostate Cancer

被引：0

作者：

Lorenz, Judith

机构：

来源：

AKTUELLE UROLOGIE | 2024年 / 55卷 / 06期

关键词：

D O I：

10.1055/a-2321-2153

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

For patients with low-risk prostate cancer, active surveillance is the preferred therapy. Studies on highly selective patient groups show excellent results from this strategy in terms of oncological prognosis, but long-term data at the population level are still lacking. A study from Canada now closes this knowledge gap.

引用

页数：1

共 50 条

[31] Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer
Haffty, Bruce G.
Lawton, Colleen A. F.
Sandler, Howard
JAMA ONCOLOGY, 2015, 1 (05) : 688 - 689
[32] USE OF HOLEP IN MEN ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
Schober, Jared
Stensland, Kristian
Mandeville, Jessica
Moinzadeh, Alireza
Canes, David
JOURNAL OF UROLOGY, 2020, 203 : E1188 - E1188
[33] Active surveillance for low-risk prostate cancer: Practice across Europe
Azmi, Aini
Dillon, Ruth
Marignol, Laure
Borghesi, Simona
Dunne, Mary
Power, Richard
O'Neill, Brian
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
[34] Enzalutamide versus active Surveillance in Patients with Low-risk Prostate Cancer
Dunst, Juergen
Krug, David
STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (02) : 201 - 203
[35] Active surveillance for low-risk prostate cancer - in pursuit of a standardized protocol
Sosnowski, Roman
Kamecki, Hubert
Daneshmand, Siamak
Rudzinski, Jan K.
Bjurlin, Marc A.
Giganti, Francesco
Roobol, Monique J.
Klotz, Laurence
CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2020, 73 (02) : 123 - 126
[36] Low-Risk Prostate Cancer Patients on Active Surveillance: Utility of Immunohistochemistry
Poveda, J.
Eldefrawy, A.
Umar, S.
Soloway, M.
Jorda, M.
MODERN PATHOLOGY, 2013, 26 : 241A - 241A
[37] Super active surveillance for low-risk prostate cancer | Opinion: Yes
Reis, Leonardo O.
Andrade, Danilo L.
Bianco, Fernando J., Jr.
INTERNATIONAL BRAZ J UROL, 2019, 45 (02): : 210 - 214
[38] Multidisciplinary Care and Pursuit of Active Surveillance in Low-Risk Prostate Cancer
Aizer, Ayal A.
Paly, Jonathan J.
Zietman, Anthony L.
Nguyen, Paul L.
Beard, Clair J.
Rao, Sandhya K.
Kaplan, Irving D.
Niemierko, Andrzej
Hirsch, Michelle S.
Wu, Chin-Lee
Olumi, Aria F.
Michaelson, M. Dror
D'Amico, Anthony V.
Efstathiou, Jason A.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3071 - 3076
[39] Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer
Cooperberg, Matthew R.
Lin, Daniel W.
Morgan, Todd M.
Chapin, Brian F.
Chen, Ronald C.
Eggener, Scott E.
JOURNAL OF UROLOGY, 2022, 207 (02): : 262 - 264
[40] Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US
Washington, Samuel L., III
Jeong, Chang Wook
Lonergan, Peter E.
Herlemann, Annika
Gomez, Scarlett L.
Carroll, Peter R.
Cooperberg, Matthew R.
JAMA NETWORK OPEN, 2020, 3 (12)

← 1 2 3 4 5 →